Skip to main content
JINLING PHARMACEUTICAL CO.,LTD logo

JINLING PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 000919 ISIN · CNE0000010W5 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,771 across all filing types
Latest filing 2016-04-25 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000919

About JINLING PHARMACEUTICAL CO.,LTD

https://www.jlyy1999.com

Jinling Pharmaceutical Co., Ltd. specializes in the research, development, manufacture, and sale of pharmaceutical products, with a focus on chemical drugs and traditional Chinese medicine preparations. The company’s product portfolio primarily targets cardiovascular and cerebrovascular diseases, anti-tumor treatments, and digestive system health. A prominent product in its lineup is the Mailuoning Injection, utilized for treating various vascular conditions. In addition to its manufacturing operations, the company is involved in the management and operation of medical institutions, integrating clinical services with pharmaceutical production. Its business model emphasizes the synergy between drug development and healthcare service delivery to provide integrated medical solutions.

Recent filings

Filing Released Lang Actions
第六届监事会第十一次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Jinling Pharmaceutical Co., Ltd. regarding the approval of the company's 2016 first quarter report and other matters. It includes details about the meeting date, attendance, and voting results. The document does not contain the actual financial statements or detailed financial data of the quarterly report but rather the approval and confirmation of the report by the Supervisory Board. The document length is short (937 characters) and serves as an announcement of the meeting resolution and approval of the quarterly report, not the report itself. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such announcements that do not contain substantive financial data or full reports.
2016-04-25 Chinese
第六届董事会第十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 10th meeting of the 6th Board of Directors of Jinling Pharmaceutical Co., Ltd. It includes details about the meeting date, attendance, and voting results on various agenda items such as approval of the 2016 Q1 report, nomination of director candidates, and proposals for shareholder meetings. The document also provides brief biographies of the nominated directors. The document length is 2300 characters, which is relatively short and primarily serves as an announcement of board meeting decisions rather than the full reports themselves. It does not contain the full quarterly report or detailed financial statements but references where the full report can be found. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management and related board meeting resolutions.
2016-04-25 Chinese
2016年第一季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2016年第一季度报告正文" which translates to "2016 First Quarter Report Main Text." It contains detailed financial data such as revenue, net profit, earnings per share, cash flow, and shareholder information for the quarter. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year clearly indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2016
2016-04-25 Chinese
独立董事关于公司第六届董事会第十次会议审议的有关议案的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on proposals reviewed at the company's sixth board of directors' tenth meeting. It references compliance with company law, securities law, stock exchange listing rules, and governance guidelines. The content focuses on nomination procedures and qualifications of board and independent director candidates. There is no financial data, earnings information, or report publication mentioned. The document is a formal board/management related announcement concerning director nominations and opinions, fitting the Board/Management Information category.
2016-04-25 Chinese
关于控股子公司南京鼓楼医院集团宿迁市人民医院新建门急诊楼和病房综合楼项目的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Jinling Pharmaceutical Co., Ltd. regarding an investment by its controlling subsidiary in a hospital construction project. It details the investment amount, project description, board approval, and risk considerations. The document is relatively short (2095 characters) and focuses on a specific investment project rather than financial results or comprehensive reporting. It does not contain financial statements or detailed financial analysis. It is an announcement of a capital investment project by the company, which fits the category of Capital/Financing Update (CAP).
2016-04-25 Chinese
独立董事提名人声明
Board/Management Information Classification · 100% confidence The document is a public statement from the board nominating an independent director candidate for the company's board. It details the qualifications, compliance with regulatory requirements, and independence of the nominee. There is no financial data, no report of financial results, no voting results, no legal proceedings, no capital changes, and no earnings information. The content is focused on board/management information specifically about the nomination of a board member. Therefore, the document fits the category of Board/Management Information (MANG). The document length is about 5,000 characters, which is consistent with a detailed announcement rather than a brief notice or a full report.
2016-04-25 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.